Clinical Trials Logo

Urinary Tract Infections clinical trials

View clinical trials related to Urinary Tract Infections.

Filter by:

NCT ID: NCT02882256 Completed - Clinical trials for Urinary Tract Infection

Video Discharge Instructions (VDI) as Adjuncts to Written Discharge Instructions in the Emergency Department

Start date: June 2016
Phase: N/A
Study type: Interventional

Patients seen in the ED with either a laceration, minor head injury, or urinary tract infection will be randomized to one of two groups. Both groups will receive the standard written discharge instructions; in addition, one group will watch video discharge instructions. Each patient will be asked to complete a short survey with questions related to the discharge instructions received in the ED, and will be called 5-7 days after the ED visit to ask questions about discharge instructions and the ED visit.

NCT ID: NCT02869165 Completed - Menopause Clinical Trials

Vaginal and Urinary Microbiome Trial

Start date: January 2017
Phase: Phase 4
Study type: Interventional

A randomized controlled trial looking at the effects of vaginal estrogen and a nonhormonal alternative on the vaginal and urinary microbiome in women with genitourinary syndrome of menopause.

NCT ID: NCT02864420 Completed - Heart Failure Clinical Trials

Hospitalization at Home: The Acute Care Home Hospital Program for Adults

Start date: September 2016
Phase: N/A
Study type: Interventional

The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and improved patient experience.

NCT ID: NCT02856633 Completed - Hypertension Clinical Trials

Preliminary Testing of the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station

Start date: July 2016
Phase: N/A
Study type: Observational

The study objective is to satisfy the testing requirements for the Qualcomm Tricorder XPRIZE Competition. This requires an oversight model using the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station to continuously monitor the patient's five core vital signs and to detect the health conditions required by the competition.

NCT ID: NCT02835456 Completed - Clinical trials for Catheter Associated Urinary Tract Infections

Does Micropattern on Urinary Catheter Surface Reduce Urinary Tract Infections?

SHARKLET
Start date: August 2016
Phase: Phase 1
Study type: Interventional

The aim of this study is to determine if the Sharklet catheter, with its unique surface micropattern, reduces infections in participants, when compared to a standard silicone catheter.

NCT ID: NCT02832258 Completed - Clinical trials for Urinary Tract Infections

Urinary Tract Infection Due to Beta-lactamase-producing Enterobacteriaceae in Children

PYELOBLSE
Start date: March 2014
Phase:
Study type: Observational

Urinary tract infection due to Extended-spectrum beta-lactamase producing enterobacteriaceae (E-ESBL UTI) become a frequent problem. A too large variety in the prescription of antibiotics for E-ESBL UTI in children and absolute recommendations regarding the optimal treatment of E-ESBL is nearly impossible at this time. Our aim was to describe the characteristics and treatments of urinary tract infections caused by Extended spectrum betalactamase-producing Enterobacteriaceae in children.

NCT ID: NCT02808000 Completed - Clinical trials for Complications; Catheter, Urinary Infection or Inflammation

BIP Foley in Prevention of CAUTI at Rehab Station

CDOC
Start date: April 21, 2016
Phase: Phase 4
Study type: Interventional

This is a prospective, cross-over, randomized, controlled, partly blinded study evaluating safety and performance of noble metal alloy urinary Catheters (BIP Foley, Bactiguard AB) of both latex and silicone. The included patients are permanently catheterized spinal cord injured patients at the Spinalis clinic at Rehab station in Stockholm, Sweden. Primary Outcome Measures: • The primary objective is to evaluate the efficacy of long term suprapubic use of BIP Foley catheters, compared to the use of standard catheters for the same time period, on re-current symptomatic catheter associated urinary tract infection (CAUTIs). Secondary Outcome Measures: • to evaluate safety/performance of the catheter, i.e. antibiotic use, bacteriuria, bacteremia, urosepsis and ICU stay. Exploratory Outcome Measures: • assessment of levels of immunological markers in urine, urinary bacterial type and resistance pattern, catheter comfort, stability of the coating, and bacterial biofilm on the catheter surface after use.

NCT ID: NCT02797613 Completed - Clinical trials for Urinary Tract Infection

Restricted Reporting for Positive Urine Cultures

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

Asymptomatic bacteriuria (AB) is a condition in which bacteria are detected in urine culture without urinary symptoms. The inappropriate use of antibiotic treatment for AB selects bacterial flora to express resistance mutations. Reducing inappropriate antibiotic use for AB is difficult, since the microbiology laboratory cannot distinguish patients with AB. The investigators study will use a restricted laboratory report requesting the physician to call the laboratory for culture results. The restricted report may reduce the rate of inappropriate treatment of AB.

NCT ID: NCT02786810 Completed - Clinical trials for Urinary Tract Infection

Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy

Start date: March 2016
Phase: Phase 2
Study type: Interventional

The study will be evaluating the efficacy and safety of a contrast drug in pediatric renal ultrasound.

NCT ID: NCT02785445 Completed - Diabetes Clinical Trials

Healthy.io Method Comparison & User Performance Study

Start date: October 2015
Phase: N/A
Study type: Interventional

The objectives of the Healthy.io Method Comparison and User Performance Study are: 1. To evaluate the performance of Dip.io Device in comparison to the ACON U500 Mission® U500 Urine Analyzer. 2. To evaluate the user performance of Dip.io Device under actual use conditions (home environment) based on a user questionnaire and rating scale.